Friday, November 13, 2015

AstraZeneca lung cancer drug given green light in US

cancer. Tagrisso targets a genetic mutation, known as T790M, that helps tumours evade current lung cancer pills. The drug … third of cancer deaths, more than breast, prostate and colorectal cancers combined. The …

No comments:

Post a Comment